Despite advances in therapy for rheumatic diseases, hydroxychloroquine remains almost
universally recommended for the treatment of systemic lupus erythematosus (SLE), and is …

Survival analyses are commonly applied to study death or other events of interest. In such
analyses, so-called competing risks may form an important problem. A competing risk is an …

Background COVID-19 has disproportionately affected minority ethnic populations in the UK.
Our aim was to quantify ethnic differences in SARS-CoV-2 infection and COVID-19 …

Importance Trends in type 2 diabetes show an increase in prevalence along with younger
age of onset. While vascular complications of early-onset type 2 diabetes are known, the …

Objective To evaluate whether early initiation of prophylactic anticoagulation compared with
no anticoagulation was associated with decreased risk of death among patients admitted to …

Alcohol consumption accounts for~ 3 million annual deaths worldwide, but uncertainty
persists about its relationships with many diseases. We investigated the associations of …

PURPOSE Tisagenlecleucel is a CD19-specific chimeric antigen receptor T-cell therapy, US
Food and Drug Administration–approved for children, adolescents, and young adults …

Background Risk of dementia after stroke is a major concern for patients and carers.
Reliable data for risk of dementia, particularly after transient ischaemic attack or minor …

In survival analysis, a competing risk is an event whose occurrence precludes the
occurrence of the primary event of interest. Outcomes in medical research are frequently …

Importance The risk of venous thromboembolism (VTE) in ambulatory COVID-19 is
controversial. In addition, the association of vaccination with COVID-19–related VTE and …